Literature DB >> 9924222

Local anaesthetic infiltration for surgical exodontia of third molar teeth: a double-blind study comparing bupivacaine infiltration with i.v. ketorolac.

D J Mellor1, A H Mellor, E M McAteer.   

Abstract

We studied 40 patients undergoing surgical removal of at least two third molar teeth under general anaesthesia. Patients were allocated randomly to one of two groups: group B (n = 20) received bupivacaine up to 2 mg kg-1, infiltrated around the inferior alveolar nerves bilaterally, and group K (n = 20) received ketorolac 10 mg i.v. at the start of surgery. There were no significant differences between the two groups in postoperative pain scores measured at 1 h using a visual analogue scale. Group K had a significantly lower incidence of side effects related to intraoral anaesthesia. Swallowing, speech and oral continence were significantly better. Group K scored higher for overall patient satisfaction, measured using a visual analogue scale. We failed to demonstrate any difference in early postoperative recovery (coughing, laryngospasm, stridor or arterial oxygen desaturation) between the groups. We conclude that the use of 0.5% bupivacaine infiltration was no more effective than a single 10-mg injection of ketorolac while giving rise to a higher rate of "minor" airway complications and lower patient acceptability.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9924222     DOI: 10.1093/bja/81.4.511

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  3 in total

Review 1.  Pathogenesis of postoperative oral surgical pain.

Authors:  Cliff K S Ong; R A Seymour
Journal:  Anesth Prog       Date:  2003

2.  Speech and language therapy for management of chronic cough.

Authors:  Claire Slinger; Syed B Mehdi; Stephen J Milan; Steven Dodd; Jessica Matthews; Aashish Vyas; Paul A Marsden
Journal:  Cochrane Database Syst Rev       Date:  2019-07-23

3.  Comparative split-mouth study of the anesthetic efficacy of 4% articaine versus 0.5% bupivacaine in impacted mandibular third molar extraction.

Authors:  Hilario Pellicer-Chover; Juan Cervera-Ballester; José M Sanchis-Bielsa; María A Peñarrocha-Diago; Miguel Peñarrocha-Diago; Berta García-Mira
Journal:  J Clin Exp Dent       Date:  2013-04-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.